Advanced disease progression occurred less often with vutrisiran than placebo in both the overall population (8.0% vs 10.7%) ...
The report highlighted in the April 5 Business article “Study: Advanced degrees in some popular fields often don’t pay off” ...
Anthropic has launched a new research effort focused on the biggest societal challenges posed by more powerful AI systems. The institute will study how advanced AI could affect the economy, the legal ...
FDA clearance advances phase 2b evaluation of teverelix in advanced prostate cancer patients where ADT choice is constrained by high baseline cardiovascular risk. Trial design targets rapid, durable ...
Dr. Andrew Pieper, director of the Brain Health Medicines Center at University Hospitals and senior author of the study, emphasizes this represents a fundamental shift in understanding the disease.
Pret Advanced Materials, LLC, a supplier of thermoplastic resins, has announced an expansion of its operations in Florence County, SC. The $18.5M investment will enhance the company's capabilities and ...
A wireless retinal implant can restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published in the New England Journal of ...
Technological advancement has become a leading cause of economic growth and global influence. The innovation nations, research nations, and technologically advanced nations are setting the future ...
The fifth generation of cellular wireless networks, 5G, isn’t just faster cellular; it’s a foundational shift in how devices, machines, and infrastructure connect in real time. With ultra-low latency, ...
Changes in screening recommendations over a decade ago may have inadvertently resulted in later diagnosis of the most common cancer in men, a new study has found. By Roni Caryn Rabin Prostate cancer ...
OpenAI announced a new product within ChatGPT called "study mode" to help students work through problems step by step. Study mode is available to Free, Plus, Pro and Team users, and it's coming to ...